The endothelium: an interface between autoimmunity and atherosclerosis in systemic lupus erythematosus? (Q37817582)

23 August 2017

1 reference

title

The endothelium: an interface between autoimmunity and atherosclerosis in systemic lupus erythematosus? (English)

1 reference

systemic lupus erythematosus

23 August 2017

0 references

1 reference

0 references

author name string

C B Narshi

series ordinal

1

1 reference

23 August 2017

I P Giles

series ordinal

2

1 reference

23 August 2017

A Rahman

series ordinal

3

1 reference

23 August 2017

publication date

7 December 2010

1 reference

23 August 2017

1 reference

23 August 2017

volume

20

1 reference

23 August 2017

issue

1

1 reference

23 August 2017

page(s)

5-13

1 reference

Systemic lupus erythematosus.

23 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0961203310382429

The bimodal mortality pattern of systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310382429

Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310382429

Premature coronary-artery atherosclerosis in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310382429

Systemic lupus erythematosus in a multiethnic US cohort (LUMINA). XXIII. Baseline predictors of vascular events.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310382429

Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310382429

Mortality in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310382429

'Not only...but also': factors that contribute to accelerated atherosclerosis and premature coronary heart disease in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310382429

Systemic lupus erythematosus and accelerated atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310382429

Prevalence of conventional and lupus-specific risk factors for cardiovascular disease in patients with systemic lupus erythematosus: A case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310382429

Risk factors for cardiovascular disease in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310382429

Atherosclerosis — An Inflammatory Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310382429

Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310382429

Innate and adaptive immunity in the pathogenesis of atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310382429

Anti-endothelial cell antibodies in patients with interstitial lung diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310382429

Antiendothelial cell antibodies in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310382429

The oxidation hypothesis of atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310382429

Anticardiolipin antibodies from patients with the antiphospholipid antibody syndrome recognize epitopes in both beta(2)-glycoprotein 1 and oxidized low-density lipoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310382429

Association of biological markers of activity of systemic lupus erythematosus with levels of anti-oxidized low-density lipoprotein antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310382429

Antibodies to oxidised LDL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310382429

Oxidative modification of low-density lipoprotein and immune regulation of atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310382429

Human-derived anti-oxidized LDL autoantibody blocks uptake of oxidized LDL by macrophages and localizes to atherosclerotic lesions in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310382429

Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H)

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310382429

Cross-reactivity of IgM and IgG anticardiolipin antibodies with oxidized-low density lipoproteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310382429

HDL and arteriosclerosis: beyond reverse cholesterol transport

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310382429

Apolipoprotein A-I inhibits the production of interleukin-1beta and tumor necrosis factor-alpha by blocking contact-mediated activation of monocytes by T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310382429

Frequency of antibodies to the cholesterol transport protein apolipoprotein A1 in patients with SLE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310382429

Cross-reactivity between anti-cardiolipin, anti-high-density lipoprotein and anti-apolipoprotein A-I IgG antibodies in patients with systemic lupus erythematosus and primary antiphospholipid syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310382429

Antibodies to high-density lipoprotein and beta2-glycoprotein I are inversely correlated with paraoxonase activity in systemic lupus erythematosus and primary antiphospholipid syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310382429

Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310382429

Lipoprotein(a) oxidation and autoantibodies: a new path in atherothrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310382429

International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310382429

Autoantibodies to modified LDLs and other phospholipid-protein complexes as markers of cardiovascular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310382429

Atherosclerosis and antiphospholipid syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310382429

Antiphospholipid antibodies and atherosclerosis: insights from systemic lupus erythematosus and primary antiphospholipid syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310382429

Activation of cultured vascular endothelial cells by antiphospholipid antibodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310382429

Antiphospholipid antibodies induced in mice by immunization with a cytomegalovirus-derived peptide cause thrombosis and activation of endothelial cells in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310382429

Animal models for antiphospholipid syndrome in pregnancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310382429

Antiphospholipid antibodies in an in vivo thrombosis model in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310382429

Patients with primary antiphospholipid antibody syndrome and without associated vascular risk factors present a normal endothelial function

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310382429

Predictors of the first cardiovascular event in patients with systemic lupus erythematosus - a prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310382429

Vascular stiffness in women with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310382429

beta2-Glycoprotein I inhibits von Willebrand factor dependent platelet adhesion and aggregation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310382429

Longitudinal ultrasound evaluation of carotid atherosclerosis in one, two and three dimensions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310382429

Three-dimensional ultrasound quantification of intensive statin treatment of carotid atherosclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310382429

Antibodies to adult human endothelial cells cross-react with oxidized low-density lipoprotein and beta 2-glycoprotein I (beta 2-GPI) in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310382429

Patients with antiphospholipid syndrome display endothelial perturbation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310382429

21 January 2018

Identifiers

DOI

10.1177/0961203310382429

1 reference

23 August 2017

1 reference